Diverse Biotech Patents

NOTE*** This is not a full list of all intellectual property nor patents granted or applications.

Patent number: 12121584

This disclosure provides multifunctional conjugate molecules comprising a target binding component covalently linked to one or more cannabinoids and/or one or more cannabinoid conjugate components. In some embodiments, the target binding component also is covalently linked to one or more active agent components. The disclosed conjugate molecules are designed to deliver therapeutic benefits of each component of the conjugate molecules and can be used to treat cancer and other disorders.

Type: Granted
Filed: November 15, 2023
Date of Patent: October 22, 2024

_______________________

Patent number: 11877988

This disclosure expands the scope and adds multiple active agents, providing multifunctional conjugate molecules comprising a target binding component covalently linked to one or more cannabinoids and/or one or more cannabinoid conjugate components. In some embodiments, the target binding component also is covalently linked to one or more active agent components. The disclosed conjugate molecules are designed to deliver therapeutic benefits of each component of the conjugate molecules and can be used to treat cancer and other disorders.

Type: Granted
Filed: June 24, 2020
Date of Patent: January 23, 2024

_______________________

Publication number: 20230173079

Abstract: This disclosure provides multifunctional conjugate molecules comprising a target binding component covalently linked to one or more cannabinoids and/or one or more cannabinoid conjugate components. In some embodiments, the target binding component also is covalently linked to one or more active agent components. The disclosed conjugate molecules are designed to deliver therapeutic benefits of each component of the conjugate molecules and can be used to treat cancer and other disorders.

Type: Application
Filed: June 24, 2020
Publication date: June 8, 2023

______________________

Publication number: 20230157992

Abstract: The present disclosure describes methods of treating acute flaccid myelitis (AFM) with one or more cannabinoids, as well as formulations and composition containing one or more cannabinoids and at least on excipient and their use for the treatment of AFM.

Type: Application
Filed: February 8, 2021
Publication date: May 25, 2023

______________________

Publication number: 20220378922

Abstract: This disclosure provides multifunctional conjugate molecules in which at least one therapeutic agent is covalently attached to a cannabinoid. The disclosed conjugate molecules are designed to deliver therapeutic benefits of both components, with release of the cannabinoid upon binding of the therapeutic agent component to its target conveying further therapeutic benefits, and can be used to treat cancer, glaucoma, confusion or dementia, and other disorders.

Type: Application
Filed: June 24, 2020
Publication date: December 1, 2022

______________________

WO2020263888A1
WIPO (PCT)

Worldwide applications
2020 JP WO US EP CA AU

2021 IL

This disclosure provides multifunctional conjugate molecules in which at least one therapeutic agent is covalently attached to a cannabinoid by means of a linker. The disclosed conjugate molecules are designed to deliver therapeutic benefits of components of the conjugate molecules and can be used to treat cancer and other disorders.